University Hospital for Tumours of Zagreb: Difference between revisions
(→Trials) |
|||
| Line 46: | Line 46: | ||
</div> | </div> | ||
== | == Experts == | ||
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> | |||
====Department of Anesthesiology, Reanimatology and Intensive Treatment==== | ====Department of Anesthesiology, Reanimatology and Intensive Treatment==== | ||
| Line 90: | Line 90: | ||
'''Contact''': Information can be found [https://www.kbcsm.hr/klinike/klinika-za-tumore/zavod-za-kirusku-onkologiju/odjel-za-onkoplastiku/ here] | '''Contact''': Information can be found [https://www.kbcsm.hr/klinike/klinika-za-tumore/zavod-za-kirusku-onkologiju/odjel-za-onkoplastiku/ here] | ||
</div> | |||
== [[Learning Resources]] == | == [[Learning Resources]] == | ||
Revision as of 16:17, 28 June 2023
The University Hospital for Tumors of Zagreb is a tumor clinic that constantly monitors and implements new methods of tumor treatment, and carries out multiple research and teaching projects. It has been part of the Sestre Milosrdnice University Hospital Centre since 2010.
See other cancer centers in Croatia.
Trials
Summary: This is a non-interventional, multi-country, multi-centre, multiple cohort prospective study, with retrospective collection of prior medical/treatment history data from medical records, designed to assess the real-world outcomes and safety of atezolizumab for indications in the existing label in the real world setting of routine clinical practice.
Sponsor, manager, or home institution: Hoffmann-La Roche
Intervention/Treatment: Drug: Atezolizumab
Number of patients: 3400 participants
Beginning Date: December 20, 2018
Last Update: December 20, 2022
Recruitment Status: Recruiting.
Cancer areas of interest: Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Hepatocellular Carcinoma
Summary: This study will evaluate the efficacy, safety and patient-reported outcomes of trastuzumab emtansine plus atezolizumab compared with trastuzumab emtansine plus placebo in participants with HER2-positive and PD-L1-positive LABC or MBC.Participants must have progressed either during or after prior trastuzumab- (+/- pertuzumab) and taxane-based therapy for LABC/MBC; or during (or within 6 months after completing) trastuzumab- (+/-pertuzumab) and taxane-based therapy in the neoadjuvant and/or adjuvant setting.
Sponsor, manager, or home institution: Hoffmann-La Roche
Intervention/Treatment: Drug: Trastuzumab Emtansine; Drug: Atezolizumab; Other: Placebo
Number of patients: 320 participants
Beginning Date: February 5, 2021
Last Update: December 14, 2022
Recruitment Status: Recruiting
Cancer areas of interest: Metastatic Breast Cancer
Experts
Department of Anesthesiology, Reanimatology and Intensive Treatment
Procedures: abdominal, gynecological, head and neck oncologic surgeries along with oncoplastic and reconstructive surgery.
Contact: Information can be found here
Department of Head and Neck Surgery
Procedures: Works on squamous cell carcinomas of the upper aerodigestive system, salivary gland, skin cancers, melanomas of the head, neck and thyroid surgical treatments and plastic-reconstructive surgery combined with radiotherapy, chemotherapy and rehabilitation.
Contact: Information can be found here
Department of Gynecological-Oncological Surgery
Procedures: Acts on prevention and early diagnosis of gynecological tumors using modern medical equipment, performs consults, local radiation therapy, and surgeries with endoscopic, vaginal and laparotomic approaches.
Contact: Information can be found here
Department of Oncological Pathology and Clinical Cytology
Procedures: Works with the methods of biopsy, immunohistochemical markers, chromogenic in situ hybridization (CISH), silver-stained in situ hybridization (SISH), and PCR analysis to examinate the received samples. Also acts on emergency cytology.
Contact: Information can be found here
Department of Internal Oncology
Procedures: unknown
Contact: Information can be found here
Department of Radiotherapy and Oncology
Procedures: unknown
Contact: Information can be found here
Institute for Oncoplastic and Reconstructive Surgery
Procedures: unknown
Contact: Information can be found here
Department of Oncoplasty
Procedures: Diagnosis by USV of the breast and abdomen, mammography, MRI, cytopuncture, biopsy, X-ray processing, and sentinel node biopsy or axillary lymph node dissection. Cancer systemic treatments used are chemotherapy, immunotherapy, hormone therapy and radiation. Performs radical, reconstructive and sparing surgical procedures involved in surgical removal of tumors and assymmetry correction. Also acts on treatment of melanoma and soft tissue sarcomas
Contact: Information can be found here
Learning Resources
Library of the University Hospital for Tumors
Content Type: Library containing publications from the field of oncology and other biomedical subjects such as surgery, radiology, anesthesia, otorhinolaryngology, internal medicine, radiotherapy, etc. The library can also be used to search medical databases, bibliometric services and certificates, and other information. Librarians can help with instructions on how to find relevant literature. There are currently about 1,722 printed books and about 14,000 volumes of magazines (130 titles).
Target Audience: Anyone in the region can access the library and create an account. The content is more relevant to providers and researchers.
Data Access: Library can be accessed here.
